Li ZX - Search Results

1

Acute coronary syndrome with severe atherosclerotic and hyperthyroidism: A case report.

Zhu HM, Zhang Y, Tang Y, Yuan H, Li ZX, Long Y. Zhu HM, et al. Among authors: li zx. World J Clin Cases. 2021 Sep 26;9(27):8127-8134. doi: 10.12998/wjcc.v9.i27.8127. World J Clin Cases. 2021. PMID: 34621871 Free PMC article.

2

Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy.

Li Z, Zhu H, Liu H, Liu D, Liu J, Jiang J, Zhang Y, Qin Z, Xu Y, Peng Y, Liu B, Long Y. Li Z, et al. J Nanobiotechnology. 2023 May 19;21(1):158. doi: 10.1186/s12951-023-01904-4. J Nanobiotechnology. 2023. PMID: 37208681 Free PMC article.

3

Synergistic dual cell therapy for atherosclerosis regression: ROS-responsive Bio-liposomes co-loaded with Geniposide and Emodin.

Li Z, Zhu H, Liu H, Liu D, Liu J, Zhang Y, Qin Z, Xu Y, Peng Y, Ruan L, Li J, He Y, Liu B, Long Y. Li Z, et al. J Nanobiotechnology. 2024 Mar 25;22(1):129. doi: 10.1186/s12951-024-02389-5. J Nanobiotechnology. 2024. PMID: 38528554 Free PMC article.

4

Targeted delivery of rosuvastatin enhances treatment of hyperhomocysteinemia-induced atherosclerosis using macrophage membrane-coated nanoparticles.

Liu D, Yang A, Li Y, Li Z, You P, Zhang H, Quan S, Sun Y, Zeng Y, Ma S, Xiong J, Hao Y, Li G, Liu B, Zhang H, Jiang Y. Liu D, et al. J Pharm Anal. 2024 Sep;14(9):100937. doi: 10.1016/j.jpha.2024.01.005. Epub 2024 Jan 13. J Pharm Anal. 2024. PMID: 39345941 Free PMC article.

5

TET1 participates in oxaliplatin-induced neuropathic pain by regulating microRNA-30b/Nav1.6.

Zhao S, Zhang JJ, Zhang MY, Yang QQ, Li ZX, Ren XH, Su SX, Si TE, Li JM, Wu HR, Chen SY, Zang WD, Cao J. Zhao S, et al. Among authors: li zx. J Biol Chem. 2025 Jan 24:108228. doi: 10.1016/j.jbc.2025.108228. Online ahead of print. J Biol Chem. 2025. PMID: 39864621

6

Fluorinated Macrocycle for Adsorptive Separation and Chromatographic Separation of Toluene and Methylcyclohexane.

Wang B, Li ZX, Wu HN, Ning ZY, Ju PF, Liu Y, Zhang ZY, Li C. Wang B, et al. Among authors: li zx. Chemistry. 2025 Jan 23:e202404566. doi: 10.1002/chem.202404566. Online ahead of print. Chemistry. 2025. PMID: 39853539

7

Discovery of sugar-based natural framework as phytopathogenic virus capsid protein inhibitors using a state-of-the-art multiple screening strategy.

Hu JH, Li ZX, Ding Y, Yang YK, Zhang TH, Liu LW, Zhou X, Yang S. Hu JH, et al. Among authors: li zx. Int J Biol Macromol. 2025 Jan 18;298:140075. doi: 10.1016/j.ijbiomac.2025.140075. Online ahead of print. Int J Biol Macromol. 2025. PMID: 39832578

8

[Meta-analysis of the efficacy of the Fuzheng Huayu formula in the treatment of hepatitis B-associated liver fibrosis or cirrhosis].

Fan Y, Hao KY, Li P, Li ZX, Liu CH, Yu YC. Fan Y, et al. Among authors: li zx. Zhonghua Gan Zang Bing Za Zhi. 2024 Dec 20;32(12):1141-1152. doi: 10.3760/cma.j.cn501113-20240612-00293. Zhonghua Gan Zang Bing Za Zhi. 2024. PMID: 39788588 Chinese.

9

Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression.

Yu XH, Xie Y, Yu J, Zhang KN, Guo ZB, Wang D, Li ZX, Zhang WQ, Tan YY, Zhang L, Jiang WT. Yu XH, et al. Among authors: li zx. World J Gastroenterol. 2025 Jan 7;31(1):101198. doi: 10.3748/wjg.v31.i1.101198. World J Gastroenterol. 2025. PMID: 39777247 Free PMC article.

10

Knowledge Mapping of Osteoimmunology:A Bibliometric Study.

Chen MZ, Wang ST, Chen DX, Peng W, Li ZX. Chen MZ, et al. Among authors: li zx. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Dec;46(6):899-908. doi: 10.3881/j.issn.1000-503X.16011. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024. PMID: 39773509 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,059 results

Search Page

Filters